The firm had a net profit of Rs 24.87 crore in FY'07, Religare said in a filing to the Bombay Stock Exchange.
The consolidated total income of the Ranbaxy group promoted company rose to Rs 896.51 crore for FY'08, from Rs 320.12 crore in the previous fiscal.
Religare, which listed itself on the domestic bourses in November last year, has 11 subsidiaries engaged in financial services targeted at retail, high net worth individuals, corporate and institutional clients.
"As we continue our onward journey, our belief is that we would continue to establish Religare as a globally trusted financial care brand and build a business model that is globally scalable and consistently committed to excellence," Religare Enterprises CEO and MD Sunil Godhwani said.
Shares of the firm were trading at Rs 392.75, down 1.26 per cent in the morning trade on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app